Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 92 users online. 5 members and 87 guests.

Most users ever online was 3,930 at 06:07 PM on 04-20-2019.

Search result already expired, please try a new search.

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    IRS says Those experiencing Homelessness can get Economic Impact Payments and other Tax Benefits
    by Staff Reporter 1
    IRS says Those experiencing Homelessness can get Economic Impact Payments and other Tax Benefits; Permanent Address Not Required | site |



    (Information contained in U.S. Internal Revenue Service [IRS] press release dated: April 15, 2021) Washington - - The Internal Revenue Service today continued an ongoing effort to help those experiencing homelessness during the pandemic by reminding people who don't have a permanent address or a bank account that they may still qualify for Economic Impact Payments and other tax benefits. While Economic Impact Payments continue to be made automatically to most people, the IRS can't issue a payment to eligible Americans when information about them isn't available in the tax agency's systems. To help people experiencing homelessness, the rural poor and other historically under-served groups, the IRS urges community groups, employers and others to share information about Economic Impact Payments and help more eligi
    ...
    04-20-2021, 04:19 AM
  • Staff Reporter 1
    U.S. Department of Education Announces More Biden-Harris Appointees
    by Staff Reporter 1
    U.S. Department of Education Announces More Biden-Harris Appointees | site |


    (Information contained in U.S. Department of Education press release dated: April 9, 2021)

    Washington - - Today, the U.S. Department of Education announced more political appointees that will lead various parts of the agency. These diverse and accomplished individuals will bring a wealth of knowledge and expertise to the agency, and work to quickly advance key education priorities for the Biden-Harris Administration.

    Levi Bohanan, Special Assistant, Office of Elementary and Secondary Education Levi Bohanan previously served in the Obama administration at the U.S. Department of Education, where he worked in the Office of Legislation and Congressional Affairs and the Office of the Secretary. Most recently, he served as a policy entrepreneur at Next100, a progressive public policy think tank created by the next generation of policy leaders, where he focused on ea
    ...
    04-18-2021, 04:54 AM
  • Staff Reporter 1
    FDA Coronavirus COVID-19 Update - - - FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
    by Staff Reporter 1
    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab | site |



    FDA says "Alternative monoclonal antibody therapies authorized to treat patients with COVID-19 remain available"


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: April 16, 2021)

    Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to bamlanivimab alone resulting in the increased risk for treatment failure, the FDA has determined that the known and potential
    ...
    04-18-2021, 04:36 AM
  • Staff Reporter 1
    FDA Coronavirus COVID-19 Update - - - FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
    by Staff Reporter 1
    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab | site |



    FDA says "Alternative monoclonal antibody therapies authorized to treat patients with COVID-19 remain available"


    (Information contained in U.S. Food and Drug Administration [FDA] press release dated: April 16, 2021)

    Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to bamlanivimab alone resulting in the increased risk for treatment failure, the FDA has determined that the known and potential
    ...
    04-18-2021, 04:36 AM

Menu

Collapse

Menu

Collapse

Working...
X